1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00662740

Title field or adapter rule

{'original_value': '1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-30T01:05:27.810728+00:00

Published At

2026-10-29T00:00:00+00:00

Record Updated At

2026-10-29

Results Posted At

2026-10-29

Source Retrieved At

2026-10-30T01:05:26.713790+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pulmonary Disease, Chronic Obstructive"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT00662740"

protocolSection.identificationModule.officialTitle

"1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

Study condition terms

• Pulmonary Disease, Chronic Obstructive (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['FDC tiotropium / salmeterol (T+S_PE)', 'FDC tiotropium / salmeterol + salmeterol (T+S_PE / S25PE)'], 'description': 'Fixed-dose combination Tiotropium/Salmeterol Inhalation Powder, Hard Polyethylene (PE) Capsule', 'name': 'FDC tiotropium / salmeterol', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo'], 'description': 'Placebo Inhalation Powder, hard PE capsule / hard gelatine capsule', 'name': 'Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['FDC tiotropium / salmeterol + salmeterol (T+S_PE / S25PE)', 'salmeterol (Salm25PE)'], 'description': 'Salmeterol Inhalation Powder, hard PE capsule', 'name': 'Salmeterol', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['tiotropium (Tio18GEL)'], 'description': 'Tiotropium, Spiriva®', 'name': 'Tiotropium (Spiriva®)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• FDC tiotropium / salmeterol (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo (protocolSection.armsInterventionsModule.interventions[].name)
• Salmeterol (protocolSection.armsInterventionsModule.interventions[].name)
• Tiotropium (Spiriva®) (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.